Connecticut 2018 Regular Session

Connecticut Senate Bill SB00166 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1		-	General Assembly Substitute Bill No. 166
2		-	February Session, 2018 _____SB00166PH____032218____
	1	+	General Assembly Raised Bill No. 166
	2	+	February Session, 2018 LCO No. 887
	3	+	00887_______PH_
	4	+	Referred to Committee on PUBLIC HEALTH
	5	+	Introduced by:
	6	+	(PH)
3	7
4	8		General Assembly
5	9
6		-	~~Substitute~~ Bill No. 166
	10	+	Raised Bill No. 166
7	11
8	12		February Session, 2018
9	13
10		-	~~_____SB00166PH____032218____~~
	14	+	LCO No. 887
11	15
12		-	AN ACT ESTABLISHING A REGISTRY OF DATA ON AMNIOTIC FLUID EMBOLISM OCCURRENCES.
	16	+	00887_______PH_
	17	+
	18	+	Referred to Committee on PUBLIC HEALTH
	19	+
	20	+	Introduced by:
	21	+
	22	+	(PH)
	23	+
	24	+	AN ACT ADDING AMNIOTIC FLUID EMBOLISM TO THE LIST OF ADVERSE EVENTS A HOSPITAL IS REQUIRED TO REPORT TO THE DEPARTMENT OF PUBLIC HEALTH.
13	25
14	26		Be it enacted by the Senate and House of Representatives in General Assembly convened:
15	27
16		-	Section 1. (NEW) (Effective July 1, 2018) On or before January 1, 2019, the Department of Public Health shall establish a registry of non-personally-identifiable data on incidents of amniotic fluid embolism. Each hospital, as defined in section 19a-490 of the general statutes, shall make available to the registry data concerning the diagnosis or treatment of amniotic fluid embolism in the hospital. The data contained in such registry may be used by the department and researchers authorized by the department for purposes of evaluating potential treatments for amniotic fluid embolism patients. The data contained in the registry shall not be subject to disclosure under the Freedom of Information Act, as defined in section 1-200 of the general statutes. The department may adopt regulations, in accordance with the provisions of chapter 54 of the general statutes, to implement the provisions of this section.
	28	+	Section 1. Subdivision (1) of subsection (a) of section 19a-127n of the general statutes is repealed and the following is substituted in lieu thereof (Effective July 1, 2018):
	29	+
	30	+	(a) (1) For purposes of this section, an "adverse event" means any event that is identified on the National Quality Forum's List of Serious Reportable Events or on a list compiled by the Commissioner of Public Health and adopted as regulations pursuant to subsection (c) of this section, which list compiled by the commissioner shall include an amniotic fluid embolism; and "corrective action plan" means a plan that (A) implements strategies that are reflective of evidenced-based best practices and that reduce the risk of similar adverse events occurring in the future, and (B) measures the effectiveness of such strategies by addressing the implementation, oversight and time lines of such strategies.
17	31
18	32
19	33
20	34
21	35		This act shall take effect as follows and shall amend the following sections:
22		-	Section 1 July 1, 2018 ~~New section~~
	36	+	Section 1 July 1, 2018 19a-127n(a)(1)
23	37
24	38		This act shall take effect as follows and shall amend the following sections:
25	39
26	40		Section 1
27	41
28	42		July 1, 2018
29	43
30		-	~~New section~~
	44	+	19a-127n(a)(1)
31	45
	46	+	Statement of Purpose:
32	47
	48	+	To add amniotic fluid embolism to the list of adverse events a hospital is required to report to the Department of Public Health.
33	49
34		-	PH Joint Favorable Subst.
35		-
36		-	PH
37		-
38		-	Joint Favorable Subst.
	50	+	[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.]